Correlation Between Polarityte and Pasithea Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Polarityte and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polarityte and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polarityte and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Polarityte and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polarityte with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polarityte and Pasithea Therapeutics.

Diversification Opportunities for Polarityte and Pasithea Therapeutics

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Polarityte and Pasithea is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Polarityte and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Polarityte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polarityte are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Polarityte i.e., Polarityte and Pasithea Therapeutics go up and down completely randomly.

Pair Corralation between Polarityte and Pasithea Therapeutics

Considering the 90-day investment horizon Polarityte is expected to under-perform the Pasithea Therapeutics. In addition to that, Polarityte is 1.68 times more volatile than Pasithea Therapeutics Corp. It trades about -0.11 of its total potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.02 per unit of volatility. If you would invest  1,370  in Pasithea Therapeutics Corp on October 11, 2024 and sell it today you would lose (1,090) from holding Pasithea Therapeutics Corp or give up 79.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy25.91%
ValuesDaily Returns

Polarityte  vs.  Pasithea Therapeutics Corp

 Performance 
       Timeline  
Polarityte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polarityte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Polarityte is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Pasithea Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Polarityte and Pasithea Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Polarityte and Pasithea Therapeutics

The main advantage of trading using opposite Polarityte and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polarityte position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.
The idea behind Polarityte and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.